pdl biopharma stock outlook week march 5 2012

pdl biopharma stock outlook week march 5 2012 ; PDL BioPharma (PDLI) has a market capitalization of $919.68 million. The company generates revenues of $362.04 million and has a net income of $199.39 million. The firm's earnings before interest, taxes, depreciation and amortization (EBITDA) amounts to $343.00 million. Because of these figures, the EBITDA margin is 94.74% (operating margin 94.72% and the net profit margin finally 55.07%).

The total debt representing 161.10% of the company's assets. Twelve trailing months earnings per share reached a value of $1.16. Last fiscal year, the company paid $0.60 in form of dividends to shareholders. PDL BioPharma has its ex-dividend date on March 05, 2012 and pays $0.15 in cash.

Here are the price ratios of the company: The P/E ratio is 5.69, Price/Sales 2.54 and Price/Book ratio is not calculable due to a negative book value. Dividend Yield: 9.13%. The beta ratio is 0.53.

For the latest updates on the stock market, visit Stock Market Today For the latest updates PRESS CTR + D or visit Stock Market news Today

Related Post: